Immunogenic chemotherapy effectively constrains KRAS-mutant lung cancer

被引：0
|
作者：
Wang, D. [1 ,2 ]
Cong, J. [1 ]
Fu, B. [1 ]
Zheng, X. [1 ]
Sun, R. [1 ,2 ]
Tian, Z. [1 ,2 ]
Wei, H. [1 ,2 ]
机构：
[1] Univ Sci & Technol China, Div Mol Med, Hefei Natl Lab Phys Sci Microscale, CAS Key Lab Innate Immun & Chron Dis,Sch Life Sci, Hefei, Anhui, Peoples R China
[2] Univ Sci & Technol China, Inst Immunol, Hefei, Anhui, Peoples R China
来源：
EUROPEAN JOURNAL OF IMMUNOLOGY | 2019年 / 49卷
关键词：
D O I：
暂无
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
P0561
引用
收藏
页码：1893 / 1893
页数：1
相关论文
共 50 条
  • [1] Immunogenic chemotherapy effectively inhibits KRAS-Driven lung cancer
    Wang, Dong
    Cong, Jingjing
    Fu, Binqing
    Zheng, Xiaohu
    Sun, Rui
    Tian, Zhigang
    Wei, Haiming
    [J]. CANCER LETTERS, 2020, 492 : 31 - 43
  • [2] Uncovering mechanisms of immune evasion in a novel immunogenic model of KRAS-mutant lung cancer
    Boumelha, Jesse
    de Carne, Sophie
    Romero, Pablo
    Moliona, Miriam
    Downward, Julian
    [J]. CANCER IMMUNOLOGY RESEARCH, 2022, 10 (01)
  • [3] Closing the door on KRAS-mutant lung cancer
    Cully, Megan
    [J]. NATURE REVIEWS DRUG DISCOVERY, 2016, 15 (11) : 747 - 747
  • [4] Closing the door on KRAS-mutant lung cancer
    Megan Cully
    [J]. Nature Reviews Drug Discovery, 2016, 15 : 747 - 747
  • [5] Current therapy of KRAS-mutant lung cancer
    Ghimessy, Aron
    Radeczky, Peter
    Laszlo, Viktoria
    Hegedus, Balazs
    Renyi-Vamos, Ferenc
    Fillinger, Janos
    Klepetko, Walter
    Lang, Christian
    Dome, Balazs
    Megyesfalvi, Zsolt
    [J]. CANCER AND METASTASIS REVIEWS, 2020, 39 (04) : 1159 - 1177
  • [6] Current therapy of KRAS-mutant lung cancer
    Aron Ghimessy
    Peter Radeczky
    Viktoria Laszlo
    Balazs Hegedus
    Ferenc Renyi-Vamos
    Janos Fillinger
    Walter Klepetko
    Christian Lang
    Balazs Dome
    Zsolt Megyesfalvi
    [J]. Cancer and Metastasis Reviews, 2020, 39 : 1159 - 1177
  • [7] Uncovering mechanisms of immune evasion in a novel immunogenic model of KRAS-mutant lung cancer.
    Boumelha, Jesse
    de Carne, Sophie
    Mugarza, Edurne
    Romero-Clavijo, Pablo
    Molina-Arcas, Miriam
    Downward, Julian
    [J]. CANCER RESEARCH, 2021, 81 (13)
  • [8] An Immunogenic Model of KRAS-Mutant Lung Cancer Enables Evaluation of Targeted Therapy and Immunotherapy Combinations
    Boumelha, Jesse
    Trecesson, Sophie de Carne
    Law, Emily K.
    Romero-Clavijo, Pablo
    Coelho, Matthew A.
    Ng, Kevin W.
    Mugarza, Edurne
    Moore, Christopher
    Rana, Sareena
    Caswell, Deborah R.
    Murillo, Miguel
    Hancock, David C.
    Argyris, Prokopios P.
    Brown, William L.
    Durfee, Cameron
    Larson, Lindsay K.
    Vogel, Rachel, I
    Suarez-Bonnet, Alejandro
    Priestnall, Simon L.
    East, Philip
    Ross, Sarah J.
    Kassiotis, George
    Molina-Arcas, Miriam
    Swanton, Charles
    Harris, Reuben
    Downward, Julian
    [J]. CANCER RESEARCH, 2022, 82 (19) : 3435 - 3448
  • [9] A combinatorial strategy for treating KRAS-mutant lung cancer
    Eusebio Manchado
    Susann Weissmueller
    John P. Morris
    Chi-Chao Chen
    Ramona Wullenkord
    Amaia Lujambio
    Elisa de Stanchina
    John T. Poirier
    Justin F. Gainor
    Ryan B. Corcoran
    Jeffrey A. Engelman
    Charles M. Rudin
    Neal Rosen
    Scott W. Lowe
    [J]. Nature, 2016, 534 : 647 - 651
  • [10] A combinatorial strategy for treating KRAS-mutant lung cancer
    Manchado, Eusebio
    Weissmueller, Susann
    Morris, John P.
    Chen, Chi-Chao
    Wullenkord, Ramona
    Lujambio, Amaia
    de Stanchina, Elisa
    Poirier, John T.
    Gainor, Justin F.
    Corcoran, Ryan B.
    Engelman, Jeffrey A.
    Rudin, Charles M.
    Rosen, Neal
    Lowe, Scott W.
    [J]. NATURE, 2016, 534 (7609) : 647 - +
12345